Barchas Isaac

SEC Form 4 insider trading activity

Barchas Isaac has filed 5 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.

On the most recent filing, Barchas Isaac is listed as Director at Immunome Inc. Inside the rolling window, Barchas Isaac reported no open-market purchases and 10 open-market sales totaling $18.3M in IMNM. The largest disclosed transaction in the window is a sale of 383,200 IMNM shares on Dec 22, 2025, worth $8.3M.

Companies traded

Other insiders at IMNM

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$18.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
IMNMSale$264KAug 12SEC ↗
IMNMSale$1.6MAug 12SEC ↗
IMNMSale$301KAug 12SEC ↗
IMNMSale$543KAug 10SEC ↗
IMNMSale$397KAug 10SEC ↗
IMNMSale$2.0MJul 7SEC ↗
IMNMSale$409KJul 7SEC ↗
IMNMSale$2.1MJul 3SEC ↗
IMNMSale$2.3MJul 3SEC ↗
IMNMSale$8.3MDec 23SEC ↗
Showing 1–10 of 10
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Barchas Isaac made?

Barchas Isaac has filed 5 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.

Which companies does Barchas Isaac trade?

Barchas Isaac has filed SEC Form 4 disclosures for 1 company, including IMNM.

When was Barchas Isaac's most recent SEC Form 4 filing?

Barchas Isaac's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.

What is Barchas Isaac's total buy and sell value in the current window?

Inside the rolling retention window, Barchas Isaac bought $0 and sold $18.3M based on SEC Form 4 filings.

What was Barchas Isaac's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 383,200 IMNM shares on 2025-12-22, worth $8.3M, per SEC Form 4 filings.